The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Siemens reveals R&D work on scanner that combines CT and PET technologies
June 24th 1998Hybrid device adds BGO detectors to CT gantryExecutives with the nuclear medicine division of Siemens Medical Systems in Hoffman Estates, IL, this month confirmed rumors about the company's efforts to build a hybrid CT/PET scanner. While the
HCFA announces FDG payment rate
June 10th 1998The nuclear medicine community has reason for celebration following the Health Care Financing Administration's June 3 announcement of a national average payment for PET scans. According to ADAC Laboratories of Milpitas, CA, HCFA stated that its Medicare
ADAC to launch PET camera line at SNM conference in Toronto
May 27th 1998Company snatched rights to UGM camera from GENuclear medicine vendor ADAC Laboratories plans to use next month’s Society of Nuclear Medicine meeting in Toronto as a launching pad for its foray into the dedicated PET market. ADAC on June 1
Toshiba to feature coincidence at SNM show
May 27th 1998Toshiba America Medical Systems will present ongoing developments in coincidence imaging at next month’s Society of Nuclear Medicine conference in Toronto. The Tustin, CA-based company will feature its Toshiba E.Cam attenuation correction and
Global supply of technetium imperiled by union walkout at Canadian reactor
May 27th 1998Technetium supplies may be exhausted by May 29It seems like déjà vu all over again. Workers again are on strike at the Canadian nuclear reactor that produces most of the world’s supply of molybdenum, which is used to make
Siemens vaults into SNMshow boosted by strong E.Cam sales
May 27th 1998Firm believes its Q1 shipments surpassed ADAC’sThe nuclear medicine group of Siemens Medical Systems continues its remarkable rebound, powered by sales of its variable-angle E.Cam gamma camera. The Hoffman Estates, IL, division believes that
SMV America to use SNM show to highlight new single-head camera
May 27th 1998DSXi is upgradable to dual-head configurationNuclear medicine vendor SMV America plans to showcase a new single-head gamma camera that is upgradable to a dual-head variable-angle model at the upcoming Society of Nuclear Medicine meeting in
Elscint seeds high-energy imaging through FDG deal with P.E.T.Net
May 27th 1998Company breaks gamma camera sales records in U.S.The nuclear medicine division of Israeli multimodality vendor Elscint hopes to make high-energy imaging easier and cheaper for its gamma camera customers through an FDG distribution deal signed this
Premier issues nuclear group buy
April 15th 1998ADAC Laboratories of Milpitas, CA, and Siemens Medical Systems of Hoffman Estates, IL, have been named the preferred vendors in a dual-source group buy of nuclear medicine equipment issued by group purchasing organization Premier. Premier members are
Siemens sells 100th PET scanner
April 1st 1998The nuclear medicine group of Siemens Medical Systems announced that it shipped its 100th ECAT Exact PET camera in March. The camera will be installed at the Rhoen Clinic in Bad Berka, Germany, according to the Hoffman Estates, IL-based division. With
ADAC’s Lowe moves to investing after reviving company’s fortunes
April 1st 1998Executive drove ADAC’s quality improvementThe last 10 years have been busy ones for David Lowe. The imaging executive helped his company, ADAC Laboratories, grow from third place and a 12% share of the U.S. nuclear medicine industry to
Immunomedics to sell MoAbs direct; firm eyes surgical probe market
March 4th 1998Company calls off relationship with MallinckrodtIf you want something done right, do it yourself. Immunomedics has taken that age-old adage to heart by implementing a plan to directly market its monoclonal antibody-based nuclear medicine imaging
Radiopharmaceutical firm Draximage explores targeted imaging agents
February 18th 1998Company's parent commits $3.5 million for R&DSmaller may be better when it comes to focusing on the nuclear medicine radiopharmaceutical marketplace. While revenues from nuclear agents can't match billion-dollar opportunities in the general
International Isotopes wins Imagyn deal
February 4th 1998Nuclear medicine start-up International Isotopes has won a major contract that will help the company in its quest to become a supplier of medical radioisotopes (SCAN 9/3/97). The company has signed a deal to provide its radioactive seeds to Imagyn
Elscint names Sardano to NM post
January 21st 1998Israeli multimodality vendor Elscint has named Joe Sardano head of its U.S. nuclear medicine business unit, a position that previously had been vacant. Prior to joining Elscint in November, Sardano was with Fisher Scientific, and has also worked for
ADAC builds high-energy imaging position by picking up rights to UGM's PET cameras
December 17th 1997Company will sell systems now marketed by GENuclear medicine vendor ADAC Laboratories scored a coup this month over rival GE Medical Systems by signing an agreement with UGM Medical Systems for UGM's low-cost PET cameras. GE had been selling the
Siemens to rebuild gamma cameras
November 12th 1997The nuclear medicine group of Siemens Medical Systems in Hoffman Estates, IL, is giving a higher profile to its gamma camera remanufacturing capability. The company last month launched its Siemens Remanufactured Product (SRP) line, which it plans to
International Isotopes inks deals
October 29th 1997Nuclear medicine start-up International Isotopes of Denton, TX, has formed alliances with several universities and institutions as part of the company's plan to develop a U.S. source for radioisotopes used for medical purposes (SCAN 9/3/97). The firm
Company retires $38 million debt from Sopha days
October 15th 1997Nuclear medicine vendor SMV of Twinsburg, OH, reported last month that it has completed the financial recapitalization plan announced earlier this year (SCAN Special Report June 1997). The deal includes the retirement of about $38 million in corporate
E.Cam spurs market resurgence at Siemens' nuclear medicine unit
October 1st 1997It's been a long road back, but the nuclear medicine group of Siemens Medical Systems can finally claim to have accomplished its long-awaited turnaround. Executives with the Hoffman Estates, IL, division are reporting a return to market share and revenue
Wagner presents results on ADAC's MCD
September 3rd 1997At last month's European Association of Nuclear Medicine Congress in Glasgow, Scotland, Dr. Henry Wagner presented preliminary results on the Molecular Coincidence Detection high-energy imaging technique under development by ADAC Laboratories of
Detector designed for orbit promises gains for digital gamma cameras
September 3rd 1997Arizona researchers investigate brain imagerThe search for black holes and new stars has led NASA engineers to develop a gamma ray detector that could vastly improve the resolution of nuclear medicine cameras. Engineers at NASA's Goddard Space
International Isotopes goes public with novel nuclear medicine strategy
September 3rd 1997Firm to develop ultra-high-resolution gamma cameraA Texas-based startup called International Isotopes is planning to take on the nuclear medicine market with a two-pronged business model that calls for manufacturing radioisotopes as well as a new
ADAC's Lowe passes CEO title to Eckert
August 20th 1997ADAC Laboratories has added CEO to Andrew Eckert's list of titles, which already includes president and COO. Giving up the CEO mantle is David Lowe, who will remain chairman of the Milpitas, CA, nuclear medicine vendor. ADAC said the transition was part
ADAC reports higher revenues despite shortfall in MCD sales
August 6th 1997Information systems unit also reports difficultiesNuclear medicine vendor ADAC Laboratories last month reported strong growth in third-quarter revenues and operating income, but the positive numbers were overshadowed by a disturbing shortfall in
Canada resolves labor dispute at reactor, but not before technetium supplies run low
July 9th 1997The nuclear medicine community is catching its breath after a one-week strike at a Canadian nuclear reactor caused a brief cutoff of the supply of molybdenum-99, the raw material for the commonly used radiotracer technetium-99m. While the strike was
U.S. effort to make molybdenum-99 awaits funding commitment from DOE
July 9th 1997The U.S. Department of Energy is moving forward with plans to use a nuclear reactor in Albuquerque to produce molybdenum-99, the raw material for several radioisotopes used in nuclear medicine. The agency's effort, however, has not moved as quickly as it
Epix and Dyax sign contrast deal
July 9th 1997The development of new nuclear medicine and MRI contrast agents is the focus of an alliance signed last month between Epix Medical and Dyax. The two Cambridge, MA, companies have agreed to join forces to spur development of agents to diagnose pulmonary